Centessa Pharmaceuticals plc (CNTA)
NASDAQ: CNTA · Real-Time Price · USD
39.46
-0.05 (-0.13%)
At close: Apr 28, 2026, 4:00 PM EDT
39.46
0.00 (0.00%)
After-hours: Apr 28, 2026, 4:10 PM EDT
Centessa Pharmaceuticals Market Cap
Centessa Pharmaceuticals has a market cap or net worth of $6.10 billion as of April 28, 2026. Its market cap has increased by 306.60% in one year.
Market Cap
6.10B
Enterprise Value
5.93B
1-Year Change
306.60%
Ranking
Category
Stock Price
$39.46
Market Cap Chart
Since the IPO on May 28, 2021, Centessa Pharmaceuticals's market cap has increased from $1.75B to $6.10B, an increase of 249.04%. That is a compound annual growth rate of 28.94%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 27, 2026 | 6.11B | 67.26% |
| Dec 31, 2025 | 3.65B | 65.43% |
| Dec 31, 2024 | 2.21B | 184.18% |
| Dec 29, 2023 | 777.13M | 165.01% |
| Dec 30, 2022 | 293.25M | -71.03% |
| Dec 31, 2021 | 1.01B | -42.11% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Belite Bio | 6.41B |
| Apogee Therapeutics | 6.39B |
| Protagonist Therapeutics | 6.29B |
| Spyre Therapeutics | 6.20B |
| Terns Pharmaceuticals | 6.11B |
| Celcuity | 6.07B |
| Erasca | 5.95B |
| Cogent Biosciences | 5.90B |